245 related articles for article (PubMed ID: 10748134)
1. Marked differences between two isoforms of human pyruvate dehydrogenase kinase.
Baker JC; Yan X; Peng T; Kasten S; Roche TE
J Biol Chem; 2000 May; 275(21):15773-81. PubMed ID: 10748134
[TBL] [Abstract][Full Text] [Related]
2. Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase.
Hiromasa Y; Roche TE
J Biol Chem; 2003 Sep; 278(36):33681-93. PubMed ID: 12816949
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Hiromasa Y; Roche TE
Biochemistry; 2004 Oct; 43(42):13442-51. PubMed ID: 15491151
[TBL] [Abstract][Full Text] [Related]
4. Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity.
Ravindran S; Radke GA; Guest JR; Roche TE
J Biol Chem; 1996 Jan; 271(2):653-62. PubMed ID: 8557670
[TBL] [Abstract][Full Text] [Related]
5. Requirements for the adaptor protein role of dihydrolipoyl acetyltransferase in the up-regulated function of the pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase.
Yang D; Gong X; Yakhnin A; Roche TE
J Biol Chem; 1998 Jun; 273(23):14130-7. PubMed ID: 9603912
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Roche TE
Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
[TBL] [Abstract][Full Text] [Related]
7. Assembly and full functionality of recombinantly expressed dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex.
Yang D; Song J; Wagenknecht T; Roche TE
J Biol Chem; 1997 Mar; 272(10):6361-9. PubMed ID: 9045657
[TBL] [Abstract][Full Text] [Related]
8. Binding of the pyruvate dehydrogenase kinase to recombinant constructs containing the inner lipoyl domain of the dihydrolipoyl acetyltransferase component.
Liu S; Baker JC; Roche TE
J Biol Chem; 1995 Jan; 270(2):793-800. PubMed ID: 7822313
[TBL] [Abstract][Full Text] [Related]
9. Partial activation of the pyruvate dehydrogenase kinase by the lipoyl domain region of E2 and interchange of the kinase between lipoyl domain regions.
Ono K; Radke GA; Roche TE; Rahmatullah M
J Biol Chem; 1993 Dec; 268(35):26135-43. PubMed ID: 8253731
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.
Tuganova A; Boulatnikov I; Popov KM
Biochem J; 2002 Aug; 366(Pt 1):129-36. PubMed ID: 11978179
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.
Tso SC; Kato M; Chuang JL; Chuang DT
J Biol Chem; 2006 Sep; 281(37):27197-204. PubMed ID: 16849321
[TBL] [Abstract][Full Text] [Related]
12. Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.
Liu S; Gong X; Yan X; Peng T; Baker JC; Li L; Robben PM; Ravindran S; Andersson LA; Cole AB; Roche TE
Arch Biochem Biophys; 2001 Feb; 386(2):123-35. PubMed ID: 11368334
[TBL] [Abstract][Full Text] [Related]
13. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.
Korotchkina LG; Patel MS
J Biol Chem; 2001 Oct; 276(40):37223-9. PubMed ID: 11486000
[TBL] [Abstract][Full Text] [Related]
14. Activated function of the pyruvate dehydrogenase phosphatase through Ca2+-facilitated binding to the inner lipoyl domain of the dihydrolipoyl acetyltransferase.
Chen G; Wang L; Liu S; Chuang C; Roche TE
J Biol Chem; 1996 Nov; 271(45):28064-70. PubMed ID: 8910418
[TBL] [Abstract][Full Text] [Related]
15. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex.
Bowker-Kinley MM; Davis WI; Wu P; Harris RA; Popov KM
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):191-6. PubMed ID: 9405293
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.
Roche TE; Hiromasa Y
Cell Mol Life Sci; 2007 Apr; 64(7-8):830-49. PubMed ID: 17310282
[TBL] [Abstract][Full Text] [Related]
17. Diversity of the pyruvate dehydrogenase kinase gene family in humans.
Gudi R; Bowker-Kinley MM; Kedishvili NY; Zhao Y; Popov KM
J Biol Chem; 1995 Dec; 270(48):28989-94. PubMed ID: 7499431
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
Li J; Kato M; Chuang DT
J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728
[TBL] [Abstract][Full Text] [Related]
19. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
Korotchkina LG; Sidhu S; Patel MS
Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
[TBL] [Abstract][Full Text] [Related]
20. Critical role of a lipoyl cofactor of the dihydrolipoyl acetyltransferase in the binding and enhanced function of the pyruvate dehydrogenase kinase.
Radke GA; Ono K; Ravindran S; Roche TE
Biochem Biophys Res Commun; 1993 Feb; 190(3):982-91. PubMed ID: 8439347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
